Related Experiment Video
Updated: May 6, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.3K
Modifiers of heart and muscle function: where genetics meets physiology
Kayleigh A Swaggart1, Elizabeth M McNally
1* 5841 South Maryland Avenue, MC 6088, Chicago, IL 606377, USA. emcnally@uchicago.edu.
Experimental Physiology
|November 12, 2013
Summary
Genetic modifiers influence muscle disease progression and therapeutic targets. Identifying these modifiers, like LTBP4, can predict disease course and aid in developing new treatments for muscular dystrophy.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Genetic disorders like muscular dystrophy present variable symptoms beyond the primary mutation.
- Genetic and environmental modifiers significantly impact disease outcomes.
- Duchenne muscular dystrophy involves dystrophin complex disruption, leading to muscle and heart disease via plasma membrane damage and fibrosis.
Purpose of the Study:
- To understand the role of genetic modifiers in muscle diseases.
- To identify specific genetic modifiers that influence disease progression and specific muscle groups.
- To explore the therapeutic potential of understanding genetic modifiers.
Main Methods:
- Mapping modifier loci using a mouse model of muscular dystrophy.
- Investigating the function of identified modifier genes, such as Ltbp4.
- Analyzing human genetic data (SNPs) to correlate with disease phenotypes in Duchenne muscular dystrophy.
Main Results:
- Multiple modifier loci affecting specific muscle groups and cardiopulmonary function in muscular dystrophy were identified.
- A locus on mouse chromosome 7, containing an Ltbp4 polymorphism, was found to modify limb skeletal muscle disease.
- LTBP4 influences sarcolemma stability and fibrosis, and LTBP4 SNPs in humans correlate with prolonged ambulation in Duchenne muscular dystrophy.
Conclusions:
- Genetic modifiers play a crucial role in the variable presentation of muscle diseases.
- LTBP4 is a key genetic modifier impacting muscle membrane stability and fibrosis, with implications for Duchenne muscular dystrophy.
- Discoveries in mouse models, like the Ltbp4 modifier, translate to human disease, offering therapeutic insights.
Related Concept Videos
01:28Human Genetics
2.0K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
01:29Pathophysiology of Cardiac Performance
2.2K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
01:27Principles of Pharmacogenetics: Types of Genetic Variants
143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
02:27Background and Environment Affect Phenotype
5.9K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
5.9K
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129